A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 4.73 USD -2.07%
Market Cap: 430.7m USD
Have any thoughts about
Aquestive Therapeutics Inc?
Write Note

Wall Street
Price Targets

AQST Price Targets Summary
Aquestive Therapeutics Inc

Wall Street analysts forecast AQST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AQST is 9.63 USD with a low forecast of 5.56 USD and a high forecast of 15.75 USD.

Lowest
Price Target
5.56 USD
17% Upside
Average
Price Target
9.63 USD
104% Upside
Highest
Price Target
15.75 USD
233% Upside

AQST Last Price Targets
Aquestive Therapeutics Inc

The latest public price target was made on Nov 6, 2024 by Thomas Flaten from Loop Capital Markets , who expects AQST stock to rise by 111% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Thomas Flaten
Loop Capital Markets
10 USD
Upside 111%
1 week ago
Nov 6, 2024
Aquestive Therapeutics (AQST) PT Raised to $10 at Lake Street Capital Markets
StreetInsider
Thomas Flaten
Loop Capital Markets
7 USD
Upside 48%
4 months ago
Jun 25, 2024
Aquestive Therapeutics (AQST) PT Lowered to $7 at Lake Street Capital Markets
StreetInsider
David Amsellem
Piper Sandler
10 USD
Upside 111%
7 months ago
Apr 11, 2024
Piper Sandler Starts Aquestive Therapeutics (AQST) at Overweight, 'he risk/reward profile associated with AQST shares is attractive'
StreetInsider
Raghuram Selvaraju
H.C. Wainwright
9 USD
Upside 90%
7 months ago
Mar 18, 2024
Aquestive Therapeutics (AQST) PT Raised to $9 at H.C. Wainwright
StreetInsider
Francois Brisebois
Oppenheimer
12 USD
Upside 154%
7 months ago
Mar 15, 2024
Aquestive Therapeutics (AQST) PT Raised to $12 at Oppenheimer
StreetInsider
Thomas Flaten
Loop Capital Markets
Price Target 10 USD
Upside/Downside 111%
View Source
Thomas Flaten
Loop Capital Markets
Price Target 7 USD
Upside/Downside 48%
View Source
David Amsellem
Piper Sandler
Price Target 10 USD
Upside/Downside 111%
View Source
Raghuram Selvaraju
H.C. Wainwright
Price Target 9 USD
Upside/Downside 90%
View Source
Francois Brisebois
Oppenheimer
Price Target 12 USD
Upside/Downside 154%
View Source
Aquestive Therapeutics Inc Competitors:
Price Targets
LAURUSLABS
Laurus Labs Ltd
18% Downside
4578
Otsuka Holdings Co Ltd
6% Downside
600422
KPC Pharmaceuticals Inc
50% Upside
CLN
Celon Pharma SA
12% Downside
002821
Asymchem Laboratories Tianjin Co Ltd
20% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
14% Upside
CTLT
Catalent Inc
4% Upside
PER
Percheron Therapeutics Ltd
176% Upside

Revenue
Forecast

Revenue Estimate
Aquestive Therapeutics Inc

For the last 6 years the compound annual growth rate for Aquestive Therapeutics Inc's revenue is -5%. The projected CAGR for the next 3 years is 15%.

-5%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Aquestive Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Aquestive Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AQST's stock price target?
Price Target
9.63 USD

According to Wall Street analysts, the average 1-year price target for AQST is 9.63 USD with a low forecast of 5.56 USD and a high forecast of 15.75 USD.

What is Aquestive Therapeutics Inc's Revenue forecast?
Projected CAGR
15%

For the last 6 years the compound annual growth rate for Aquestive Therapeutics Inc's revenue is -5%. The projected CAGR for the next 3 years is 15%.

Back to Top